Skip to Main Content

Browse issues

Volume 54, Issue 7, 1 April 2012

1 April News

Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages i–ii, https://doi.org/10.1093/cid/cis129

In the Literature

Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages iii–iv, https://doi.org/10.1093/cid/cir1002

Crossing Borders: One World, Global Health

Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages v–vi, https://doi.org/10.1093/cid/cis248

ARTICLES AND COMMENTARIES

Kristin A. Swedish and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 891–898, https://doi.org/10.1093/cid/cir1036

Randomized controlled trials demonstrated the efficacy of quadrivalent human papillomavirus (qHPV) in primary prevention of human papillomavirus (HPV) infection and HPV-related cancers/precancerous lesions. Our study suggests that qHPV may be effective in prevention of recurrent high-grade anal neoplasia among men who have sex with men.

Mary S. Gable and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 899–904, https://doi.org/10.1093/cid/cir1038

Anti-N-methyl-D-aspartic acid receptor encephalitis rivals viral etiologies as a cause of encephalitis within the California Encephalitis Project cohort. Thus it merits a prominent place on the differential diagnosis of encephalitis, allowing for prompt treatment and recovery.

Vivian Luchsinger and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 905–912, https://doi.org/10.1093/cid/cir955

In a study of 356 adults with community-acquired pneumonia, respiratory syncytial virus was a frequent pathogen (13%). Serology and real-time reverse-transcription polymerase chain reaction improved the detection of repiratory syncytial virus. High respiratory syncytial virus serum-neutralizing antibody levels protected against severe pneumonia.

Dionissios Neofytos and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 913–921, https://doi.org/10.1093/cid/cir969

Administration of intravenous voriconazole to patients with creatinine clearance <50 mL/minute for at least 3 days did not affect renal function. Underlying disease, baseline liver impairment, and other drugs (penicillins, fluoroquinolones, pressors, immunosuppressants) were the strongest predictors of renal dysfunction.

Kenneth E. Schmader and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 922–928, https://doi.org/10.1093/cid/cir970

In subjects aged 50–59 years, the zoster vaccine (ZV) significantly reduced the incidence of herpes zoster (ZV: 1.99/1000 person-years; placebo: 6.57/1000 person-years) and was well tolerated.

Hong-tian Li and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 929–930, https://doi.org/10.1093/cid/cir974
Faizel H. A. Sukhrie and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 931–937, https://doi.org/10.1093/cid/cir971

Enhanced sampling yielded a 232% increase of identified shedders. Here, symptomatic patients and healthcare workers (HCWs) were more often involved in transmission events than asymptomatic shedders. Asymptomatic HCWs rarely contributed to transmission, despite high levels of fecal virus shedding.

William P. Goins and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 938–945, https://doi.org/10.1093/cid/cir973

In this randomized, open-label trial of healthcare personnel previously vaccinated with acellular pertussis vaccine, noninferiority of daily symptom monitoring without postexposure prophylaxis (PEP) compared with antibiotic PEP was not demonstrated for preventing infection following pertussis exposure.

Hartmut J. Ehrlich and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 946–954, https://doi.org/10.1093/cid/cir959

A Vero cell culture–derived seasonal influenza vaccine provides consistently high levels of protection against cell culture–confirmed infection over a complete influenza season. Influenza symptoms are also less severe and of shorter duration in individuals who become infected despite vaccination.

Chinyere K. Okoro and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 955–963, https://doi.org/10.1093/cid/cir1032

Invasive nontyphoidal Salmonella Typhimurium disease is a common and frequently recurrent cause of bacteremia across sub-Saharan Africa. We use high-resolution single nucleotide polymorphism analysis to distinguish between reinfection and recrudescence in disease recurrence within single individuals over time.

BRIEF REPORTS

Marcelo Takahiro Mitui and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 964–967, https://doi.org/10.1093/cid/cir957
Aurélie Cobat and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 968–971, https://doi.org/10.1093/cid/cir972

PHOTO QUIZ

Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Page 972, https://doi.org/10.1093/cid/cir958

INVITED ARTICLES

AGING AND INFECTIOUS DISEASES

David van Duin
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 973–978, https://doi.org/10.1093/cid/cir927

HIV/AIDS

David L. Thomas and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 979–983, https://doi.org/10.1093/cid/cir882

HIV/AIDS

Amy C. Justice and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 984–994, https://doi.org/10.1093/cid/cir989

The Veterans Aging Cohort Study (VACS) Index, based on age and 8 routine clinical tests, is strongly correlated with 3 biomarkers of inflammation: interleukin 6 (IL-6), D-dimer, and soluble CD14 (sCD14). After adjustment for the VACS Index, D-dimer and sCD14, but not IL-6, remain independently associated with mortality.

Shanmugam Saravanan and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 995–1000, https://doi.org/10.1093/cid/cir967

Analysis of human immunodeficiency virus type 1 pol gene sequences from 107 patients receiving second-line antiretroviral therapy (ART) revealed that a high prevalence of resistance mutations among second-line ART-experienced patients limits the ART-sequencing options, suggesting darunavir as the third-line drug in India.

Theodore D. Ruel and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 1001–1009, https://doi.org/10.1093/cid/cir1037

Human immunodeficiency virus (HIV)-infected antiretroviral therapy-naive Ugandan children with CD4 cell counts of ∼350 cells/μL and percentages of >15% have significant motor and cognitive deficits compared with HIV-uninfected children. Study of whether early initiation of treatment could prevent or reverse such deficits is needed.

Thor A. Wagner and Lisa M. Frenkel
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 1010–1012, https://doi.org/10.1093/cid/cir1041
Peter L. Havens and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 1013–1025, https://doi.org/10.1093/cid/cir968

In this randomized, double-blind, placebo-controlled trial of human immunodeficiency virus–infected youths aged 18–25, vitamin D3, 50000 IU once monthly for 3 months decreased parathyroid hormone in participants treated with tenofovir-containing antiretroviral regimens but not in those participants whose regimens did not contain tenofovir.

Michael J. Silverberg and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 1026–1034, https://doi.org/10.1093/cid/cir1012

In a large North American cohort study, anal cancer incidence rates were substantially higher for HIV-infected men who have sex with men, other men, and women compared with HIV-uninfected individuals. Rates increased from 1996–1999 to 2000–2003 but plateaued by 2004–2007.

ANSWER TO THE PHOTO QUIZ

Oliver Bader and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 1035–1036, https://doi.org/10.1093/cid/cir943

CORRESPONDENCE

Yoav Keynan
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Page 1037, https://doi.org/10.1093/cid/cir1010
Arlene C. Seña and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 1037–1038, https://doi.org/10.1093/cid/cir1021
J. R. Harris and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages 1038–1039, https://doi.org/10.1093/cid/cir1019

ERRATUM

Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Page 1040, https://doi.org/10.1093/cid/cis007

ELECTRONIC ARTICLES

Jeffrey L. Jones and Jacquelin M. Roberts
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages e58–e61, https://doi.org/10.1093/cid/cir990

Although numbers of toxoplasmosis-related hospitalizations in the United States have declined since the mid-1990s, there continue to be many such hospitalizations (>3500 estimated in 2008), especially among human immunodeficiency virus–infected persons and those in racial or ethnic minority groups.

Solène Le Gal and others
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Pages e62–e71, https://doi.org/10.1093/cid/cir996

An outbreak of Pneumocystis jirovecii infections in renal transplant recipients was investigated using P. jirovecii type identification combined with analysis of patient encounters. The results suggest that colonized patients represent infectious sources in a context of nosocomial acquisition of the fungus.

STANDING MATERIAL

Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Page NP, https://doi.org/10.1093/cid/cis145
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Page NP, https://doi.org/10.1093/cid/cis150
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Page NP, https://doi.org/10.1093/cid/cis147
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Page NP, https://doi.org/10.1093/cid/cis146
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Page NP, https://doi.org/10.1093/cid/cis148
Clinical Infectious Diseases, Volume 54, Issue 7, 1 April 2012, Page NP, https://doi.org/10.1093/cid/cis149
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close